IPO & secondary preview -- Week of May 28, 2007

Posted May 29th 2007 9:56AM by Joseph Lazzaro
Filed under: SEC Filings, Other Issues, Deals

Wall Street's equity market shifts into summer mode -- historically a lighter season -- with just three IPOs on the docket this week.

Those deals tentatively scheduled to price include:

IPOs:

Thursday

Amicus Therapeutics (FOLD), a 5M-share IPO for this gene-based medicine company. Morgan Stanley and Merrill Lynch are the lead managers. Filing range: $14.00-$16.00.

Friday

Jazz Pharmaceuticals (JAZZ), a 6M-share IPO for this pharmaceutical company. Morgan Stanley and Lehman Brothers are the lead managers. Filing range: $24.00-$26.00.

LDK Solar (LDK), a 17.384M-share IPO for this solar cells company. Morgan Stanley and UBS Investment are the lead managers. Filing range: $25.00-$27.00.

- -

For the latest market intelligence on IPOs, Syndicate, and after-market trades, check out The Fly Syndicate at www.theflyonthewall.com. [Subscription required.]

Tags: Amicus, equity market, EquityMarket, IPOs, Jazz Pharmaceuticals, LDK Solar, Lehman Brothers, LehmanBrothers, Merrill Lynch, Morgan Stanley, MorganStanley, UBS